GB Sciences Louisiana Receives All Approvals and Announces the Opening of the Full Tissue Propagation Cannabis Cultivation at LSU Agricultural Center
Increases production and ensures a continuous supply of therapeutic cannabis for Louisiana patients.
LAS VEGAS, April 16, 2019/PR Newswire/– GB Sciences, Inc. (OTCQB: GBLX), a partner in GB Sciences Louisiana, LLC, is announcing that all cultivation operations at LSU Agricultural Center are now open. This will allow a continuous harvest for patients by increasing GB Sciences Louisiana’s production capacity 500%.
“Our expansion is important for Louisiana’s therapeutic cannabis patients,” said GB Sciences Louisiana President John Davis, “Full-scale operations mean a consistent and continuous supply of therapeutic cannabis across the state.”
GB Sciences Louisiana’s two previous successful harvests, in the smaller proof-of-concept facility, passed state testing requirements — allowing GB Sciences Louisiana to start final product formulations immediately. These formulations will be submitted to Louisiana’s state regulator for continuous testing and ultimately distributed to the nine licensed pharmacies around the state. The new production facility is equipped with modular clean-room technology for use in the production of plants and formulation of final products.
GB Sciences Louisiana was selected by LSU Agricultural Center as its cannabis cultivation partner thorough a competitive public bid and presentation process in 2017. GB Sciences Louisiana was approved by Louisiana’s state regulator in August 2018 to grow, extract, and formulate cannabis in the smaller proof-of-concept facility on site while construction on the main production facility was underway. GB Sciences Louisiana completed the construction of the main production facility in October 2018. Since that date, the facility has received the “certificate of occupancy” from the state regulator and their Standard Operating Procedures have been approved.
About GB Sciences, Inc.
GB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company’s goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about GB Sciences, Inc., go to: http://gbsciences.com.
About Louisiana State University Agricultural Center
The Louisiana State University Agricultural Center (“LSU AgCenter” or “AgCenter”) is an institution under the supervision and management of the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (the “LSU Board of Supervisors”). The AgCenter’s mission is to provide the people of Louisiana with research-based educational information that will improve their lives and economic well-being. The LSU AgCenter includes the Louisiana Agricultural Experiment Station, which conducts Agricultural and Renewable Natural Resource-based research, and the Louisiana Cooperative Extension Service, which extends the knowledge derived from research to the people of the state. The LSU AgCenter plays an integral role in supporting agricultural industries, enhancing the environment, and improving the quality of life through its 4-H youth, family and consumer sciences, and community development programs.
This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company’s control. It is possible that the Company’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company’s business and financial and other results, are contained in the Company’s filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.
Note: Although the Company’s research and development activities are not illegal, the production and sale of cannabis products violate federal laws as they presently exist.
GB Sciences, Inc., 3550 West Teco Ave., Las Vegas, NV 89118
Liz Bianco, email@example.com